REFERENCES
- Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl 1994. Current protocols in molecular biology. John Wiley and Sons, New York, N.Y.
- Balkwill, F., and J. Taylor-Papadimitriou 1978. Interferon affects both G1 and S+G2 in cells stimulated from quiescence to growth. Nature 274: 798–801.
- Bromberg, J., and J. E. Darnell, Jr. Unpublished observations.
- Bromberg, J. F., C. M. Horvath, Z. Wen, R. D. Schreiber, Darnell J. E., Jr. 1996. Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma. Proc. Natl. Acad. Sci. USA 93: 7673–7678.
- Campbell, G. S., C. L. Yu, R. Jove, and C. Carter-Su 1997. Constitutive activation of JAK1 in Src-transformed cells. J. Biol. Chem. 272: 2591–2594.
- Cao, X., A. Tay, G. R. Guy, and Y. H. Tan 1996. Activation and association of Stat3 with Src in v-Src transformed cell lines. Mol. Cell. Biol. 16: 1595–1603.
- Chiang, C. M., and R. G. Roeder 1993. Expression and purification of general transcription factors by FLAG epitope-tagging and peptide elution. Pept. Res. 6: 62–64.
- Chin, Y. E., M. Kitagawa, W. C. Su, Z. H. You, Y. Iwamoto, and X. Y. Fu 1996. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1. Science 272: 719–722.
- Cressman, D. E., L. E. Greenbaum, R. A. DeAngelis, G. Ciliberto, E. E. Furth, V. Poli, and R. Taub 1996. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274: 1379–1383.
- Darnell, J. E.Jr., I. M. Kerr, and G. R. Stark 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415–1421.
- de Vries-Smits, A. M., B. M. Burgering, S. J. Leevers, C. J. Marshall, and J. L. Bos 1992. Involvement of p21ras in activation of extracellular signal-regulated kinase 2. Nature 357: 602–604.
- Fried, M., and D. M. Crothers 1981. Equilibria and kinetics of lac repressor-operator interactions by polyacrylamide gel electrophoresis. Nucleic Acids Res. 9: 6505–6525.
- Fukada, T., M. Hibi, Y. Yamanaka, M. Takahashi-Tezuka, Y. Fujitani, T. Yamaguchi, K. Nakajima, and T. Hirano 1996. Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of Stat3 in anti-apoptosis. Immunity 5: 449–460.
- Gouilleux-Gruart, V., F. Gouilleux, C. Desaint, J. F. Claisse, J. C. Capiod, J. Delobel, R. Weber-Nordt, I. Dusanter-Fourt, F. Dreyfus, B. Groner, and L. Prin 1996. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients. Blood 87: 1692–1697.
- Horvath, C. M., J. Bromberg, and J. E. Darnell, Jr. Unpublished observations.
- Horvath, C. M., Z. Wen, Darnell J. E., Jr. 1995. A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 9: 984–994.
- Karras, J. G., Z. H. Wang, L. Huo, R. G. Howard, D. A. Frank, and T. L. Rothstein 1997. Signal transducer and activator of transcription-3 (Stat3) is constitutively activated in normal, self renewing B-1 cells but only inducibly expressed in conventional B lymphocytes. J. Exp. Med. 185: 1035–1042.
- Land, H., L. F. Parada, and R. A. Weinberg 1983. Tumorigenic conversion of primary fibroblasts requires at least two cooperating oncogenes. Nature 304: 596–602.
- Lin, S., T. Kikuchi, W. J. Pledger, and I. Tamm 1986. Interferon inhibits the establishment of competence in G0/S-phase transition. Science 233: 356–359.
- MacAuley, A., and T. Pawson 1988. Cooperative transforming activities of ras, myc, and src viral oncogenes in nonestablished rat adrenocortical cells. J. Virol. 62: 4712–4721.
- Migone, T. S., J. X. Lin, J. C. Cereseto, J. C. Mulloy, J. J. O’Shea, G. Franchini, and W. J. Leonard 1995. Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-1. Science 269: 79–81.
- Minami, M., M. Inoue, S. Wei, K. Takeda, M. Matsumoto, T. Kishimoto, and S. Akira 1996. Stat3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. Proc. Natl. Acad. Sci. USA 93: 3963–3966.
- Nakajima, K., Y. Yamanaka, K. Nakae, H. Kojima, M. Ichiba, N. Kiuchi, T. Kitaoka, T. Fukada, M. Hibi, and T. Hirano 1996. A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J. 15: 3651–3658.
- Sabe, H., M. Okada, H. Nakagawa, and H. Hanafusa 1992. Activation of c-Src in cells bearing v-Crk and its suppression by Csk. Mol. Cell. Biol. 12: 4706–4713.
- Sartor, C. I., M. L. Dziubinski, C. L. Yu, R. Jove, and S. P. Ethier 1997. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT huma breast cancer cells. Cancer Res. 57: 978–987.
- Schindler, C., Darnell, J. E.Jr. 1995. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu. Rev. Biochem. 64: 621–651.
- Shuai, K., J. Liao, and M. M. Song 1996. Enhancement of antiproliferative activity of gamma interferon by the specific inhibition of tyrosine dephosphorylation of Stat1. Mol. Cell. Biol. 16: 4932–4941.
- Shuai, K., C. Schindler, V. R. Prezioso, Darnell J. E., Jr. 1992. Activation of transcription by IFN-γ: tyrosine phosphorylation of a 91 kD DNA binding protein. Science 259: 1808–1812.
- Suematsu, S., T. Matsusaka, T. Matsuda, S. Ohno, J. Miyazaki, K. Yamamura, T. Hirano, and T. Kishimoto 1992. Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin 6 transgenic mice. Proc. Natl. Acad. Sci. USA 89: 232–235.
- Takeda, K., K. Noguchi, W. Shi, T. Tanaka, M. Matsumoto, N. Yoshida, T. Kishimoto, and S. Akira 1997. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc. Natl. Acad. Sci. USA 94: 3801–3804.
- Wagner, B. J., T. E. Hayes, C. J. Hoban, and B. H. Cochran 1990. The SIF binding element confers sis/PDGF inducibility onto the c-fos promoter. EMBO J. 9: 4477–4484.
- Weber-Nordt, R. M., C. Egen, J. Wehinger, W. Ludwig, V. Gouilleux-Gruart, R. Mertelsmann, and J. Finke 1996. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines. Blood 88: 809–816.
- Wen, Z., and J. E. Darnell, Jr. Unpublished data.
- Wen, Z., Z. Zhong, Darnell J. E., Jr. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82: 241–250.
- Yu, C. L., D. Meyer, G. S. Campbell, A. C. Larner, C. Carter-Su, J. Schwartz, and R. Jove 1995. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein. Science 269: 81–83.
- Zhang, Q., I. Nowak, E. C. Vonderheid, A. H. Rook, M. E. Kadin, P. C. Nowell, L. M. Shaw, and M. A. Wasik 1996. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. Proc. Natl. Acad. Sci. USA 93: 9148–9153.
- Zhong, Z., Z. Wen, Darnell J. E., Jr. 1994. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264: 95–98.